A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : C1-INH / C1 esterase inhibitor

[Related PubMed/MEDLINE]
Total Number of Papers: 330
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   C1-INH  (>> Co-occurring Abbreviation)
Long Form:   C1 esterase inhibitor
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 An anesthetic experience of hereditary angioedema type I patient undertook total laparoscopic hysterectomy - A case report. FFP, HAE
2021 A Possibly Fatal Outcome of Oral Contraceptive Therapy: Estrogen Triggered Hereditary Angioedema Attack in An Adolescent. HAE, OC, PCOS
2021 A robust multiplexed assay to quantify C1-inhibitor, C1q, and C4 proteins for in vitro diagnosis of hereditary angioedema from dried blood spot. DBS, HAE
2021 Clinical manifestations of hereditary angioedema and a systematic review of treatment options. HAE
2021 Clinical profile of hereditary angioedema from a tertiary care centre in India. HAE
2021 Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis. ---
2021 Contact activated kallikrein generation is reduced six months after gastric bypass. EKP, FXII, HK, rs, RYGB
2021 Effect of Anabolic-Androgenic Steroid Abuse on the Contact Activation System. AAS, CAS, EKP, FXII, HK
2021 Indirect Comparison of Lanadelumab and Intravenous C1-INH Using Data from the HELP and CHANGE Studies: Bayesian and Frequentist Analyses. ARR, HAE, ITC
10  2021 Physicochemical and Biological Characterization of rhC1INH Expressed in CHO Cells. CHO, HAE/AAE, rhC1INH
11  2021 Plasma-derived and recombinant C1 esterase inhibitor: Binding profiles and neuroprotective properties in brain ischemia/reperfusion injury. MBL, pd, rh
12  2021 Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study. AEs, CVID, IVIG, rhC1INH
13  2021 The Genetics of Hereditary Angioedema: A Review. ANGPT1, HS, KNG1, MYOF, PLG
14  2021 Unusual presentation of linear wrist blisters associated with hereditary angioedema: The first case report in Taiwan. HAE
15  2020 A Case of Prolonged Angioedema After Cardiac Surgery. ACEi, AE
16  2020 A first of its kind quantitative functional C1-esterase inhibitor lateral flow assay for hereditary angioedema point-of-care diagnostic testing. fC1-INH, HAE, LFA
17  2020 A Novel C1-Esterase Inhibitor Oxygenator Coating Prevents FXII Activation in Human Blood. ---
18  2020 A novel functional C1 inhibitor activity assay in dried blood spot for diagnosis of Hereditary angioedema. C1s, DBS, HAE
19  2020 Age-dependent possible role of contact-activated blood coagulation factor XII as a potential contributor to the “bradykinin storm” in COVID-19 patients C1INH
20  2020 C1 esterase inhibitor use in the management of lisinopril-induced angioedema: A case series. ACEi-AE
21  2020 Characteristics of patients with C1 esterase inhibitor deficiency: a single center study. FMF, HAE
22  2020 Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review. ADs, HAE
23  2020 Current medical management of hereditary angioedema: Follow-up survey of US physicians. HAE, LTP
24  2020 Definition and classification of hereditary angioedema. HAE, SERPING1
25  2020 Effect of complement C1-esterase inhibitor on brain edema and inflammation after mild traumatic brain injury in an animal model. TBI
26  2020 Effects of Ischemic Preconditioning and C1 Esterase Inhibitor Administration following Ischemia-Reperfusion Injury in a Rat Skin Flap Model. IPC
27  2020 Hereditary Angioedema Attack in Utero and Treatment of the Mother and Fetus. HAE
28  2020 Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database. ---
29  2020 Immune Evasion Strategies of Relapsing Fever Spirochetes. C4BP, FH, FHL-1, RF, RFB
30  2020 In Vitro Modeling of Bradykinin-Mediated Angioedema States. ACE, HAE, iBK
31  2020 Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedema. AEs, HAE
32  2020 Novel SERPING1 gene mutations and clinical experience of type 1 hereditary angioedema from North India. HAE, TA
33  2020 Novel Use of Fresh Frozen Plasma in Treating Hereditary Angioedema: A Success Story From Pakistan. FFP, HAE
34  2020 Perioperative Management of Patients With Hereditary Angioedema With Special Considerations for Cardiopulmonary Bypass. ACE, BK, HAE
35  2020 Reference range for C1-esterase inhibitor (C1 INH) in the third trimester of pregnancy. AFE
36  2020 Study of angiopoietin and plasminogen genes in hereditary angioedema. ANGPT1, HAE, PLG, SNP
37  2020 Successful perioperative management of three patients with hereditary angioedema without C1 esterase inhibitor therapy: A developing country perspective. HAE
38  2020 The Role of C1-Esterase Inhibitors in the Management of Vasogenic Edema in Glioblastoma. BBB, GB
39  2020 [Hereditary angioedema in Costa Rica]. ---
40  2019 A hereditary angioedema screening in two villages, based on an index case, and identification of a novel mutation, "1033G>T", at the SERPING1 gene. HAE
41  2019 C1 esterase inhibitor in pediatric cardiac surgery with cardiopulmonary bypass plays a vital role in activation of the complement system. CPB, GCMC
42  2019 C1 Esterase Inhibitor Reduces BBB Leakage and Apoptosis in the Hypoxic Developing Mouse Brain. BBB
43  2019 C1-esterase inhibitor enhances thrombin generation and spatial fibrin clot propagation in the presence of thrombomodulin. PC, TEEs, TG, TM, TP
44  2019 Design and characterization of alpha1-antitrypsin variants for treatment of contact system-driven thromboinflammation. alpha1-AT, APC, FXII
45  2019 Early treatment with C1 esterase inhibitor improves weight but not memory deficits in a rat model of status epilepticus. BM, NOR, OF, SE
46  2019 Enhancement of Tissue Factor Expression in Monocyte-Derived Dendritic Cells by Pentraxin 3 and Its Modulation by C1 Esterase Inhibitor. LPS, moDCs, PTX3, TF
47  2019 Hereditary and acquired angioedema. HAE
48  2019 Hereditary angioedema: an update on causes, manifestations and treatment. ---
49  2019 Identification of the recently described plasminogen gene mutation p.Lys330Glu in a family from Northern Germany with hereditary angioedema. HAE, PLG
50  2019 IONIS-PKKRx a Novel Antisense Inhibitor of Prekallikrein and Bradykinin Production. HAE, PKK
51  2019 NOX2 Expression Is Increased in Keratinocytes After Burn Injury. ROS
52  2019 Pediatric hereditary angioedema: what the otolaryngologist should know. FDA, HAE
53  2019 Recurrent swelling and pain in the abdomen and joints in a patient with hereditary angioedema and Ehlers-Danlos syndrome. EDS, HAE
54  2019 Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study. HAE, SC
55  2019 Successful Long-Term Prophylactic Treatment With Subcutaneous C1 Esterase Inhibitor in a Patient With Hereditary Angioedema. AE-QoL, HAE, s.c
56  2018 A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients. DGF, IRI
57  2018 An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema. FXII, HAE, HK, RNAi, siRNA
58  2018 Bordetella pertussis isolates vary in their interactions with human complement components. ---
59  2018 Combination Therapy with Low-Dose IVIG and a C1-esterase Inhibitor Ameliorates Brain Damage and Functional Deficits in Experimental Ischemic Stroke. IVIG, TLRs
60  2018 Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema. COMPACT, FDA, HAE
61  2018 Hereditary angioedema: the plasma contact system out of control. HAE
62  2018 Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies. HAE
63  2018 Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema. CL, HAE, s.c
64  2018 Practical use of C1 esterase inhibitor concentrate for clinical amniotic fluid embolism. AFE
65  2018 Practicalities of a reduced volume formulation of a C1-INH concentrate for the treatment of hereditary angioedema: real-life experience. HAE
66  2018 Repeated attacks of type III hereditary angioedema with factor XII mutation during pregnancy. ---
67  2018 Severity of hereditary angioedema, prevalence, and diagnostic considerations. HAE
68  2018 The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury-Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor. AMI, I/R
69  2018 Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema. HAE, s.c
70  2018 Usefulness of C1 esterase inhibitor protein concentrate in the management of hereditary angioedema of oropharyngeal tissue. ---
71  2018 [Acquired C1esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases]. ACE, ARBs, HAE
72  2017 Angioedema in the emergency department: a practical guide to differential diagnosis and management. ACEIs, ED
73  2017 Complement activation contributes to ventilator-induced lung injury in rats. VILI, VILI-C
74  2017 Effect of C1-INH on ischemia/reperfusion injury in a porcine limb ex vivo perfusion model. I/R
75  2017 Human plasma-derived C1 esterase inhibitor concentrate has limited effect on house dust mite-induced allergic lung inflammation in mice. BALF, HDM
76  2017 In vitro Inhibition of Canine Complement-Mediated Hemolysis. IMHA
77  2017 Pharmacologic Complement Inhibition in Clinical Transplantation. aHUS, AMR, HLA, PNH
78  2017 Recombinant C1 Esterase Inhibitor Reduces Cytokine Storm in an Ex Vivo Whole Blood Model. IL, TNF-alpha
79  2017 Recruitment of Human C1 Esterase Inhibitor Controls Complement Activation on Blood Stage Plasmodium falciparum Merozoites. ---
80  2016 A Case of Type 2 Hereditary Angioedema With SERPING1 Mutation. ---
81  2016 A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE). HAE
82  2016 Acquired C1 esterase inhibitor deficiency in lymphomas: prevalence, symptoms, and response to treatment. CLL, DLBCL, FL, SMZL
83  2016 Angiotensin-converting enzyme inhibitor-associated angioedema treated with c1-esterase inhibitor: A case report and review of the literature. AAE, ACEI
84  2016 Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury. ---
85  2016 C1 esterase inhibitor ameliorates ischemia reperfusion injury in a swine musculocutaneous flap model. AST, CK, IRI
86  2016 C1 Inhibitor Limits Organ Injury and Prolongs Survival in Swine Subjected to Battlefield Simulated Injury. TH
87  2016 Complement Inhibition for Prevention and Treatment of Antibody-Mediated Rejection in Renal Allograft Recipients. ABMR
88  2016 Diagnosis and screening of patients with hereditary angioedema in primary care. HAE
89  2016 Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency. HAE, pdC1-INH
90  2016 Efficacy of Treatment of Non-hereditary Angioedema. ACEi-AE, AE, FFP, TA
91  2016 Myocardial infarction induces atrial inflammation that can be prevented by C1-esterase inhibitor. MI
92  2016 Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema. HAE
93  2016 New insight into the effects of heparinoids on complement inhibition by C1-inhibitor. AP, CP, LP
94  2016 On the value of therapeutic interventions targeting the complement system in acute myocardial infarction. AMI
95  2016 Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study. AMR, PP, TG
96  2016 Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor. polyP
97  2016 Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance. HAE
98  2016 Soluble IgM links apoptosis to complement activation in early alcoholic liver disease in mice. SIgM
99  2015 Current state of hereditary angioedema management: a patient survey. ED, HAE, HAE-nl-C1INH, QoL
100  2015 Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema. AAD, HAE